Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

PharmAthene Company Profile (NYSE:PIP)

Consensus Ratings for PharmAthene (NYSE:PIP) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.33 (189.86% upside)

Analysts' Ratings History for PharmAthene (NYSE:PIP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/18/2014Noble FinancialLower Price Target$6.00ViewTweet This Rating  Share This Rating on StockTwits
8/11/2014AegisBoost Price Target$6.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014HC WainrightInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
3/15/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/6/2013AegisInitiated CoverageBuy$6.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/19/2012 forward)